402
Views
8
CrossRef citations to date
0
Altmetric
Review Article

Biochemical markers of time since death in cerebrospinal fluid: A first step towards “Forensomics”

, , , &
Pages 274-286 | Received 21 Dec 2018, Accepted 12 May 2019, Published online: 06 Jun 2019

References

  • Madea B. Estimation of the time since death. 3rd ed. Boca Raton (FL): CRC Press; 2015.
  • Donaldson AE, Lamont IL. Estimation of post-mortem interval using biochemical markers. Aust J Forensic Sci. 2014;46:8–26.
  • Swain R, Kumar A, Sahoo J, et al. Estimation of post-mortem interval: a comparison between cerebrospinal fluid and vitreous humour chemistry. J Forensic Leg Med. 2015;36:144–148.
  • Zhou C, Byard RW. Factors and processes causing accelerated decomposition in human cadavers—an overview. J Forensic Leg Med. 2011;18:6–9.
  • Coe JI. Postmortem chemistry update. Emphasis on forensic application. Am J Forensic Med Pathol. 1993;14:91–117.
  • Madea B. Methods for determining time of death. Forensic Sci Med Pathol. 2016;12:451–485.
  • Madea B. Is there recent progress in the estimation of the postmortem interval by means of thanatochemistry? Forensic Sci Int. 2005;151:139–149.
  • Henry JB, Smith FA. Estimation of the postmortem interval by chemical means. Am J Forensic Med Pathol. 1980;1:341–347.
  • Wyler D, Marty W, Bär W. Correlation between the post-mortem cell content of cerebrospinal fluid and time of death. Int J Legal Med. 1994;106:194–199.
  • Palmiere C, Mangin P. Postmortem chemistry update part I. Int J Legal Med. 2012;126:187–198.
  • Palmiere C, Mangin P. Postmortem chemistry update part II. Int J Legal Med. 2012;126:199–215.
  • Arroyo A, Rosel P, Marron T. Cerebrospinal fluid: postmortem biochemical study. J Clin Forensic Med. 2005;12:153–156.
  • Yadav J, Deshpande A, Arora A, et al. Estimation of time since death from CSF electrolyte concentration in Bhopal region of central India. Leg Med Tokyo Jpn. 2007;9:309–313.
  • Mason JK, Klyne W, Lennox B. Potassium levels in the cerebrospinal fluid after death. J Clin Pathol. 1951;4:231–233.
  • Murray E. Potassium levels in cerebrospinal fluid and their relation to duration of death. J Forensic Sci. 1958;3:480–485.
  • Naumann HN. Cerebrospinal fluid electrolytes after death. Proc Soc Exp Biol Med. 1958;98:16–18.
  • Naumann HN. Postmortem chemistry of the vitreous body in man. Arch Ophthalmol. 1959;62:356–363.
  • Fraschini F, Muller E, Zanoboni A. Post-mortem increase of potassium in human cerebrospinal fluid. Nature. 1963;198:1208.
  • Schleyer F. Methods of forensic science. Vol. 2, New York (NY): Wiley; 1963.
  • Paulson GW, Stickney D. Cerebrospinal fluid after death. Confin Neurol. 1971;33:149–162.
  • Kärkelä JT. Critical evaluation of postmortem changes in human autopsy cisternal fluid. Enzymes, electrolytes, acid-base balance, glucose and glycolysis, free amino acids and ammonia. Correlation to total brain ischemia. J Forensic Sci. 1993;38:603–616.
  • Eliakis E, Eliakis A, Coutselinis A. Fluctuations des électrolytes du liquide céphalo-rachidien après la mort et leur signification pour la détermination du moment du décès. Ann Méd lég. 1966;46(2):108–111.
  • Eliakis E, Eliakis A, Coutselinis A. Détermination de l’heure de la mort par le dosage du phosphore inorganique du liquide cérébro-spinal. Ann Méd lég. 1965;45(4):366–371.
  • Naumann HN. Studies on postmortem chemistry. Am J Clin Pathol. 1950;20:314–324.
  • Nixon DA. Cerebrospinal fluid inositol and its rise in post-mortem specimens. J Physiol (Lond). 1955;129:272–280.
  • Pucher G, Burd L. A preliminary study of the chemistry of postmortem blood and spinal fluid. Bull Buffalo Gen Hosp. 1925;3:11–13.
  • Kärkelä J, Scheinin M. Tryptophan and biogenic amine metabolites in post-mortem human cisternal fluid: effects of post-mortem interval and agonal time. J Neurol Sci. 1992;107:239–245.
  • Girela E, Villanueva E, Irigoyen P, et al. Free amino acid concentrations in vitreous humor and cerebrospinal fluid in relation to the cause of death and postmortem interval. J Forensic Sci. 2008;53:730–733.
  • Jenkins WJ. The significance of blood and cerebrospinal fluid urea levels estimated after death. J Clin Pathol. 1953;6:110–113.
  • Fekete JF, Brunsdon D. The use of routine laboratory tests in postmortem examinations. Can Soc Forensic Sci J. 1974;7:238–254.
  • Endo T, Hara S, Kuriiwa F, et al. Postmortem changes in the levels of monoamine metabolites in human cerebrospinal fluid. Forensic Sci Int. 1990;44:61–68.
  • Balbi T, Fusco M, Vasapollo D, et al. The presence of trace amines in postmortem cerebrospinal fluid in humans. J Forensic Sci. 2005;50:630–632.
  • Musshoff F, Menting T, Madea B. Postmortem serotonin (5-HT) concentrations in the cerebrospinal fluid of medicolegal cases. Forensic Sci Int. 2004;142:211–219.
  • Dogan KH, Unaldi M, Demirci S. Evaluation of postmortem cerebrospinal fluid S100B protein and serotonin levels: comparison of suicidal versus nonsuicidal deaths in Konya, Turkey. J Forensic Sci. 2016;61:1285–1291.
  • Quan L, Ishikawa T, Hara J, et al. Postmortem serotonin levels in cerebrospinal and pericardial fluids with regard to the cause of death in medicolegal autopsy. Leg Med Tokyo Jpn. 2011;13:75–78.
  • Takata T, Kitao T, Miyaishi S. Relationship between post-mortem interval and creatine concentration in vitreous humour and cerebrospinal fluid. Aust J Forensic Sci. 2014;46:160–165.
  • Harkness RA, Lund RJ. Cerebrospinal fluid concentrations of hypoxanthine, xanthine, uridine and inosine: high concentrations of the ATP metabolite, hypoxanthine, after hypoxia. J Clin Pathol. 1983;36:1–8.
  • Manzke H, Krämer M, Dörner K. Post-mortem oxypurine concentrations in the CSF. Adv Exp Med Biol. 1986;195 Pt A:587–591.
  • Madea B, Käferstein H, Hermann N, et al. Hypoxanthine in vitreous humor and cerebrospinal fluid–a marker of postmortem interval and prolonged (vital) hypoxia? Remarks also on hypoxanthine in SIDS. Forensic Sci Int. 1994;65:19–31.
  • Praetorius E, Poulsen H, Dupont H. Uric acid, xanthine and hypoxanthine in the cerebrospinal fluid. Scand J Clin Lab Invest. 1957;9:133–137.
  • Carpenter KH, Bonham JR, Worthy E, et al. Vitreous humour and cerebrospinal fluid hypoxanthine concentration as a marker of pre-mortem hypoxia in SIDS. J Clin Pathol. 1993;46:650–653.
  • Morris JA, Harrison LM, Telford DR. Postmortem cerebrospinal fluid pleocytosis: a marker of inflammation or postmortem artifact? Int J Pediatr. 2012;2012:964074.
  • Mangin P, Lugnier AA, Chaumont AJ, et al. Forensic significance of postmortem estimation of the blood cerebrospinal fluid barrier permeability. Forensic Sci Int. 1983;22:143–149.
  • Morihara T, Kudo T, Ikura Y, et al. Increased tau protein level in postmortem cerebrospinal fluid. Psychiatry Clin Neurosci. 1998;52:107–110.
  • Osuna E, Perez-Carceles MD, Luna A, et al. Efficacy of cerebro-spinal fluid biochemistry in the diagnosis of brain insult. Forensic Sci Int. 1992;52:193–198.
  • Finehout EJ, Franck Z, Relkin N, et al. Proteomic analysis of cerebrospinal fluid changes related to postmortem interval. Clin Chem. 2006;52:1906–1913.
  • Maeda H, Michiue T, Zhu B-L, et al. Analysis of cardiac troponins and creatine kinase MB in cerebrospinal fluid in medicolegal autopsy cases. Leg Med Tokyo Jpn. 2009;11:S266–S268.
  • Wang Q, Michiue T, Ishikawa T, et al. Combined analyses of creatine kinase MB, cardiac troponin I and myoglobin in pericardial and cerebrospinal fluids to investigate myocardial and skeletal muscle injury in medicolegal autopsy cases. Leg Med Tokyo Jpn. 2011;13:226–232.
  • Chen J-H, Inamori-Kawamoto O, Michiue T, et al. Cardiac biomarkers in blood, and pericardial and cerebrospinal fluids of forensic autopsy cases: a reassessment with special regard to postmortem interval. Leg Med Tokyo Jpn. 2015;17:343–350.
  • Dito WR. Transaminase activity in postmortem cerebrospinal fluid. Am J Clin Pathol. 1964;42:360–363.
  • Fan K. 2', 3'-cyclic nucleotide 3'-phosphohydrolase activity in postmortem human spinal fluids. Neurosci Lett. 1980;19:229–233.
  • Parmar AK, Menon SK. Estimation of postmortem interval through albumin in CSF by simple dye binding method. Sci Justice. 2015;55:388–393.
  • Li D-R, Michiue T, Zhu B-L, et al. Evaluation of postmortem S100B levels in the cerebrospinal fluid with regard to the cause of death in medicolegal autopsy. Leg Med (Tokyo). 2009;11 Suppl:1:S273–S275.
  • Wester P, Bateman DE, Dodd PR, et al. Agonal status affects the metabolic activity of nerve endings isolated from postmortem human brain. Neurochem Pathol. 1985;3:169–180.
  • Sommer JB, Gaul C, Heckmann J, et al. Does lumbar cerebrospinal fluid reflect ventricular cerebrospinal fluid? A prospective study in patients with external ventricular drainage. Eur Neurol. 2002;47:224–232.
  • Weisner B, Bernhardt W. Protein fractions of lumbar, cisternal, and ventricular cerebrospinal fluid. Separate areas of reference. J Neurol Sci. 1978;37:205–214.
  • Reiber H. Dynamics of brain-derived proteins in cerebrospinal fluid. Clin Chim Acta. 2001;310:173–186.
  • Young SN, Garelis E, Lal S, et al. Tryptophan and 5-hydroxyindoleacetic acid in human cerebrospinal fluid. J Neurochem. 1974;22:777–779.
  • Nordin C, Siwers B, Bertilsson L. Site of lumbar puncture influences levels of monoamine metabolites. Arch Gen Psychiatry. 1982;39:1445.
  • Garland J, Philcox W, Kesha K, et al. Differences in sampling site on postmortem cerebrospinal fluid biochemistry: a preliminary study. Am J Forensic Med Pathol. 2018;39:304–308.
  • Schoonenboom NSM, Mulder C, Vanderstichele H, et al. Effects of processing and storage conditions on amyloid beta (1-42) and tau concentrations in cerebrospinal fluid: implications for use in clinical practice. Clin Chem. 2004;51:189–195.
  • Mattsson N, Andreasson U, Persson S, et al. CSF biomarker variability in the Alzheimer’s Association quality control program. Alzheimers Dement. 2013;9:251–261.
  • Teunissen CE, Verwey NA, Kester MI, et al. Standardization of assay procedures for analysis of the CSF biomarkers amyloid β((1-42)), tau, and phosphorylated tau in Alzheimer’s disease: report of an international workshop. Int J Alzheimers Dis. 2010;2010:635053.
  • Wu A. Tietz clinical guide to laboratory tests. 4th ed. St. Louis (MO): Saunders; 2006.
  • Sjögren M, Vanderstichele H, Agren H, et al. Tau and Abeta42 in cerebrospinal fluid from healthy adults 21-93 years of age: establishment of reference values. Clin Chem. 2001;47:1776–1781.
  • Henssge C. Death time estimation in case work. I. The rectal temperature time of death nomogram. Forensic Sci Int. 1988;38:209–236.
  • Henssge C, Madea B, Gallenkemper E. Death time estimation in case work. II. Integration of different methods. Forensic Sci Int. 1988;39:77–87.
  • Henssge C. Rectal temperature time of death nomogram: dependence of corrective factors on the body weight under stronger thermic insulation conditions. Forensic Sci Int. 1992;54:51–66.
  • Henssge C, Althaus L, Bolt J, et al. Experiences with a compound method for estimating the time since death. I. Rectal temperature nomogram for time since death. Int J Legal Med. 2000;113:303–319.
  • Henssge C, Althaus L, Bolt J, et al. Experiences with a compound method for estimating the time since death. II. Integration of non-temperature-based methods. Int J Legal Med. 2000;113:320–331.
  • Baccino E, Martin LDS, Schuliar Y, et al. Outer ear temperature and time of death. Forensic Sci Int. 1996;83:133–146.
  • Cattaneo C, Di Giancamillo A, Campari O, et al. Infrared tympanic thermography as a substitute for a probe in the evaluation of ear temperature for post-mortem interval determination: a pilot study. J Forensic Leg Med. 2009;16:215–217.
  • Camps F. Establishment of the time of death—a critical assessment. J Forensic Sci. 1959;4:73–82.
  • Madea B. Estimation of the time since death. In: Siegel JA, Saukko PJ, editors. Encyclopedia of forensic sciences. Waltham (MA): Academic Press; 2013. p. 229–238.
  • Boja ES, Kinsinger CR, Rodriguez H, et al. Integration of omics sciences to advance biology and medicine. Clin Proteomics. 2014;11:45.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.